Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Yahoo acquires Commonstock to elevate retail investment platform In a strategic move to solidify its position as a leading financial resource, Yahoo has announced the acquisition… byPallavi MadhirajuAugust 26, 2023